{"title":"台湾非爱滋病患者结核病复发率及相关危险因素:一项回顾性队列研究","authors":"Che-min Hsu , Chia-Ju Wu , Chih-Jung Chang , Sheng-Wei Pan , Yen-Han Tseng , Jhong-Ru Huang , Wei-Juin Su , Jia-Yih Feng , Yuh-Min Chen","doi":"10.1016/j.jiph.2025.102912","DOIUrl":null,"url":null,"abstract":"<div><h3>Background/Purpose</h3><div>Despite effective short-course anti-tuberculosis (TB) treatments, TB recurrence remains a significant public health issue. This study aims to investigate the rate of TB recurrence and its associated risk factors in Taiwan.</div></div><div><h3>Methods</h3><div>Patients with active TB who completed anti-TB treatment from 2012 to 2019 at Taipei Veterans General Hospital were identified and included in the analysis. All enrolled cases were followed for up to 6 years to identify TB recurrence using the CDC registration database in Taiwan. The evolving trends in annual TB recurrence rates were examined. Independent demographic, clinical, and microbiological factors associated with TB recurrence were also investigated.</div></div><div><h3>Results</h3><div>A total of 1875 patients with active TB were enrolled in the analysis. The overall TB recurrence rate was determined to be 2.0 % (434 per 100,000 person-years), with a median follow-up duration of 72 months. A notable decline in the recurrence rate was observed post-2017. The peak recurrence rate was observed during the second year following treatment completion. Independent factors associated with TB recurrence included a body mass index (BMI) <20 kg/m² (adjusted hazard ratio [aHR]: 4.38, 95 % CI:1.70–11.30, p = 0.002), a history of previous TB (aHR 4.28, 95 % CI: 1.77–10.35, p = 0.001), and 2-month sputum TB culture non-conversion (aHR:3.37, 95 % CI: 1.36–8.38, p = 0.009). These observations were further corroborated through subgroup analyses, encompassing pulmonary TB and culture-confirmed pulmonary TB.</div></div><div><h3>Conclusions</h3><div>The TB recurrence rate in Taiwan is low and shows a declining trend. Independent factors associated with TB recurrence included low BMI, previous TB, and 2-month sputum TB culture non-conversion.</div></div>","PeriodicalId":16087,"journal":{"name":"Journal of Infection and Public Health","volume":"18 11","pages":"Article 102912"},"PeriodicalIF":4.0000,"publicationDate":"2025-07-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Recurrence of tuberculosis and associated risk factors among Non-HIV patients in Taiwan: A retrospective cohort study\",\"authors\":\"Che-min Hsu , Chia-Ju Wu , Chih-Jung Chang , Sheng-Wei Pan , Yen-Han Tseng , Jhong-Ru Huang , Wei-Juin Su , Jia-Yih Feng , Yuh-Min Chen\",\"doi\":\"10.1016/j.jiph.2025.102912\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Background/Purpose</h3><div>Despite effective short-course anti-tuberculosis (TB) treatments, TB recurrence remains a significant public health issue. This study aims to investigate the rate of TB recurrence and its associated risk factors in Taiwan.</div></div><div><h3>Methods</h3><div>Patients with active TB who completed anti-TB treatment from 2012 to 2019 at Taipei Veterans General Hospital were identified and included in the analysis. All enrolled cases were followed for up to 6 years to identify TB recurrence using the CDC registration database in Taiwan. The evolving trends in annual TB recurrence rates were examined. Independent demographic, clinical, and microbiological factors associated with TB recurrence were also investigated.</div></div><div><h3>Results</h3><div>A total of 1875 patients with active TB were enrolled in the analysis. The overall TB recurrence rate was determined to be 2.0 % (434 per 100,000 person-years), with a median follow-up duration of 72 months. A notable decline in the recurrence rate was observed post-2017. The peak recurrence rate was observed during the second year following treatment completion. Independent factors associated with TB recurrence included a body mass index (BMI) <20 kg/m² (adjusted hazard ratio [aHR]: 4.38, 95 % CI:1.70–11.30, p = 0.002), a history of previous TB (aHR 4.28, 95 % CI: 1.77–10.35, p = 0.001), and 2-month sputum TB culture non-conversion (aHR:3.37, 95 % CI: 1.36–8.38, p = 0.009). These observations were further corroborated through subgroup analyses, encompassing pulmonary TB and culture-confirmed pulmonary TB.</div></div><div><h3>Conclusions</h3><div>The TB recurrence rate in Taiwan is low and shows a declining trend. Independent factors associated with TB recurrence included low BMI, previous TB, and 2-month sputum TB culture non-conversion.</div></div>\",\"PeriodicalId\":16087,\"journal\":{\"name\":\"Journal of Infection and Public Health\",\"volume\":\"18 11\",\"pages\":\"Article 102912\"},\"PeriodicalIF\":4.0000,\"publicationDate\":\"2025-07-23\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Infection and Public Health\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S1876034125002618\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"INFECTIOUS DISEASES\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Infection and Public Health","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1876034125002618","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"INFECTIOUS DISEASES","Score":null,"Total":0}
Recurrence of tuberculosis and associated risk factors among Non-HIV patients in Taiwan: A retrospective cohort study
Background/Purpose
Despite effective short-course anti-tuberculosis (TB) treatments, TB recurrence remains a significant public health issue. This study aims to investigate the rate of TB recurrence and its associated risk factors in Taiwan.
Methods
Patients with active TB who completed anti-TB treatment from 2012 to 2019 at Taipei Veterans General Hospital were identified and included in the analysis. All enrolled cases were followed for up to 6 years to identify TB recurrence using the CDC registration database in Taiwan. The evolving trends in annual TB recurrence rates were examined. Independent demographic, clinical, and microbiological factors associated with TB recurrence were also investigated.
Results
A total of 1875 patients with active TB were enrolled in the analysis. The overall TB recurrence rate was determined to be 2.0 % (434 per 100,000 person-years), with a median follow-up duration of 72 months. A notable decline in the recurrence rate was observed post-2017. The peak recurrence rate was observed during the second year following treatment completion. Independent factors associated with TB recurrence included a body mass index (BMI) <20 kg/m² (adjusted hazard ratio [aHR]: 4.38, 95 % CI:1.70–11.30, p = 0.002), a history of previous TB (aHR 4.28, 95 % CI: 1.77–10.35, p = 0.001), and 2-month sputum TB culture non-conversion (aHR:3.37, 95 % CI: 1.36–8.38, p = 0.009). These observations were further corroborated through subgroup analyses, encompassing pulmonary TB and culture-confirmed pulmonary TB.
Conclusions
The TB recurrence rate in Taiwan is low and shows a declining trend. Independent factors associated with TB recurrence included low BMI, previous TB, and 2-month sputum TB culture non-conversion.
期刊介绍:
The Journal of Infection and Public Health, first official journal of the Saudi Arabian Ministry of National Guard Health Affairs, King Saud Bin Abdulaziz University for Health Sciences and the Saudi Association for Public Health, aims to be the foremost scientific, peer-reviewed journal encompassing infection prevention and control, microbiology, infectious diseases, public health and the application of healthcare epidemiology to the evaluation of health outcomes. The point of view of the journal is that infection and public health are closely intertwined and that advances in one area will have positive consequences on the other.
The journal will be useful to all health professionals who are partners in the management of patients with communicable diseases, keeping them up to date. The journal is proud to have an international and diverse editorial board that will assist and facilitate the publication of articles that reflect a global view on infection control and public health, as well as emphasizing our focus on supporting the needs of public health practitioners.
It is our aim to improve healthcare by reducing risk of infection and related adverse outcomes by critical review, selection, and dissemination of new and relevant information in the field of infection control, public health and infectious diseases in all healthcare settings and the community.